Synopsis of recent research by authors named "Xiaming Lu"
- Xiaming Lu's research explores the role of oncolytic vaccinia virus in cancer treatment, highlighting its potential applications in both breast and pancreatic cancers.
- In a recent study, Lu found that targeting the cyclin-dependent kinase inhibitor p21 can lead to increased growth of breast cancer cells while diminishing the efficacy of the vaccinia virus as a therapeutic agent.
- Additionally, Lu's previous work demonstrated a synergistic effect between gemcitabine and an engineered oncolytic vaccinia virus in pancreatic cancer, showcasing the virus's ability to enhance chemosensitivity and improve treatment outcomes.